Characterization of NADPH-dependent methemoglobin reductase as a heme-binding protein present in erythrocytes and liver (1992)

Peer-Reviewed Study · F. Xu, K. S. Quandt, D. E. Hultquist · March 15, 1992

F. Xu et al., 1992-03-15: Purification and characterization of the erythrocyte NADPH-dependent reductase that drives methylene blue-dependent methemoglobin reduction; the authors report it is also present in liver and question whether its main role is reductive.

An NADPH-dependent reductase, first shown in the 1930s to catalyze the methylene blue-dependent reduction of methemoglobin in erythrocytes, has now been characterized as a high-affinity heme-binding protein and has been detected in liver.

Abstract

F. Xu et al., 1992-03-15: Purification and characterization of the erythrocyte NADPH-dependent reductase that drives methylene blue-dependent methemoglobin reduction; the authors report it is also present in liver and question whether its main role is reductive. Laboratory biochemistry (purified bovine erythrocyte enzyme; bovine and rat liver and erythrocytes; immunoblotting). Country: United States. No dose/route (in vitro); enzyme concentration in bovine erythrocytes estimated at 10 microM; protohemin binding Kd 7 nM. Funder: NIH grant AG-07046 (NIA). Conflicts: none declared in the record. Comparator: none. Note for the verifier: the abstract itself flags that the protein's 'weak reductase activity' brings into question the long-held belief that it functions as a reductase – a caveat that bears on how confidently the NADPH-reductase step should be described. Full text on PMC (PMC48610, scanned) not machine-readable. Study type: lab.